The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 17, 2020
Filed:
Nov. 23, 2016
Applicants:
Immunocore Limited, Abingdon, GB;
Adaptimmune Limited, Abingdon, GB;
Inventors:
Alex Powlesland, Abingdon, GB;
Chandramouli Chillakuri, Abingdon, GB;
Dhaval Sangani, Abingdon, GB;
Graham Hood, Abingdon, GB;
Alina Popa, Abingdon, GB;
Assignee:
IMMUNOCORE LIMITED, Oxfordshire, GB;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); C07K 14/47 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); A61K 35/17 (2015.01); A61K 38/03 (2006.01); C07K 14/725 (2006.01); C12N 15/62 (2006.01); C12N 15/79 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1774 (2013.01); A61K 35/17 (2013.01); A61K 38/03 (2013.01); A61K 39/0011 (2013.01); A61P 35/00 (2018.01); C07K 14/4748 (2013.01); C07K 14/7051 (2013.01); C12N 15/62 (2013.01); C12N 15/79 (2013.01);
Abstract
The present invention relates to novel peptides derived from Kita-kyushu lung cancer antigen (CT83), complexes comprising such peptides bound to recombinant MHC molecules, and cells presenting said peptide in complex with MHC molecules. Also provided by the present invention are binding moieties that bind to the peptides and/or complexes of the invention. Such moieties are useful for the development of immunotherapeutic reagents for the treatment of diseases such as cancer.